Increased serum IgG antibody response to Merkel cell polyomavirus oncoproteins in patients with autoimmune rheumatic diseases
International Immunology · 2025
DOI: 10.1093/intimm/dxaf029 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, 2025. Verfasst von Chiara Mazziotta und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Hauptthemen laut MEDLINE: Merkel cell polyomavirus, Immunoglobulin G, Antibodies, Viral, Autoimmune Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Fondo di Ateneo per la ricerca.
Abstract (Originalsprache)
Autoimmune rheumatic diseases (AIRDs) encompass a spectrum of disorders with a partially understood pathogenesis. A role for polyomaviruses in AIRDs occurrence has been reported. However, the involvement of Merkel cell polyomavirus (MCPyV), the main causative factor of Merkel cell carcinoma (MCC), an aggressive skin neoplasm related to immunosuppression, in AIRDs is unknown. The prevalence/serological profiles of immunoglobulin G (IgG) antibodies to MCPyV large and small T (LT/sT) oncoproteins and viral capsid proteins 1 and 2 (VP1/2) were investigated herein in 540 immunosuppressive treatment-naive AIRD patients, encompassing 447 rheumatoid arthritis (RA) and 93 ankylosing spondylitis (AS) patients by seven MCPyV-specific immunoassays. Control sera from 500 healthy subjects (HS) and 128 MCC patients were included. MCPyV DNA and LT/VP1 mRNAs were evaluated in peripheral blood mononuclear cells (PBMCs) from 75 randomly selected AIRD patients. AIRD patients exhibited higher prevalence and levels (optical densities) of serum anti-oncoprotein IgGs (12%–13%, 0.2–0.6) compared to HS (2%–7%, 0.1–0.4), but lower than MCC patients (70%–83%, 0.2–0.7) (P < .05), with the increase being more pronounced in AS (24%–29%, 0.3–0.8) than in RA (9%–11%, 0.2–0.8) (P < .05). Conversely, similar rates and levels of serum anti-capsid proteins IgGs were determined in most cases between study and control groups (60%–73%, 0.1–0.3) (P > .05). Moreover, receiver operating characteristic (ROC) curves indicated that the MCPyV serology can discriminate AIRD patients from HS (P < .0001). A fraction (11%) of AIRD PBMCs tested MCPyV DNA (7.4 ± 2.6 [copy/104 cells]) and mRNA-positive (0.5–0.1 [1/ΔCt]), while matched sera showed high rates and levels of anti-oncoproteins IgGs (38%–75%, 0.2–2). Our study provides the first evidence that AIRD patients are immunologically responsive to MCPyV oncoproteins, with a fraction of these patients presenting an increased presentation of MCPyV LT and sT antigens, possibly due to viral LT/sT oncogene expression in their PBMCs. These data suggest an association between MCPyV infection and AIRDs pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
- Center for Studies on Gender Medicine - Department of Medical Sciences, University of Ferrara. Ferrara. Italy.
- "Biologie des infections à polyomavirus" Team, UMR1282, University of Tours, Tours, France.
- Medicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
- Department of Biomedical and Neuromotor Sciences (DIBINEM), Alma Mater Studiorum University of Bologna, Bologna, Italy.
- Rheumatology Unit, Department of Medicine, University of Verona, Verona, Italy.
ORCID-Profile: Chiara Mazziotta, Mauro Tognon, Fernanda Martini, John Charles Rotondo
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Fondo di Ateneo per la ricerca
Zitieren
APA
Mazziotta, C., Tonnini, G., Oimo, M., Cervellera, C. F., Badiale, G., Touzé, A., Assirelli, E., Neri, S., Ursini, F., Rossini, M., Adami, G., Gatti, D., Govoni, M., Tognon, M., Martini, F., & Rotondo, J. C. (2025). Increased serum IgG antibody response to Merkel cell polyomavirus oncoproteins in patients with autoimmune rheumatic diseases. International Immunology. https://doi.org/10.1093/intimm/dxaf029
Vancouver
Mazziotta C, Tonnini G, Oimo M, Cervellera CF, Badiale G, Touzé A, et al. Increased serum IgG antibody response to Merkel cell polyomavirus oncoproteins in patients with autoimmune rheumatic diseases. International Immunology. 2025. doi:10.1093/intimm/dxaf029
BibTeX
@article{Mazziotta2025,
author = {Mazziotta, Chiara and Tonnini, Giulia and Oimo, Milena and Cervellera, Christian Felice and Badiale, Giada and Touzé, Antoine and Assirelli, Elisa and Neri, Simona and Ursini, Francesco and Rossini, Maurizio and Adami, Giovanni and Gatti, Davide and Govoni, Marcello and Tognon, Mauro and Martini, Fernanda and Rotondo, John Charles},
title = {Increased serum IgG antibody response to Merkel cell polyomavirus oncoproteins in patients with autoimmune rheumatic diseases},
journal = {International Immunology},
year = {2025},
doi = {10.1093/intimm/dxaf029}
}
EUVIMED